Skip to Main Content

Latest Internal Medicine News

Quantitative Assay Measures Low Levels of HER2 with Renewed Accuracy

Researchers at Yale Cancer Center have developed a new quantitative assay to measure the amount of HER2 protein in patients with breast cancer with increased accuracy. The improved data may provide new options for treatment for patients previously found ineligible for treatment based on traditional HER2 screening assays. The findings were published today in Laboratory Investigation.

Read more